Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Neoadjuvant HER2+
Brain Cancer
Bone Metastases
Business Management
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Genitourinary Cancers
Head & Neck Cancers
Hematologic Oncology
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Non-Hodgkin Lymphoma
Oncology Nursing News
Patient Resources
Precision Medicine in Oncology
®
Sarcomas
Special Reports in Personalized Cancer Care
Supportive Care
Online CME
Interactive Publications
SELECT A TOPIC
CURRENT VIEW
All Specialties
▲
Education ▲
Education ▼
Register
|
Login
Conference Coverage
Videos
NewsNetwork
OncLive
®
TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
OS by PS in Metastatic Pancreatic Cancer Treatment- Data From an Exploratory Subgroup Analysis
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Neoadjuvant HER2+
More >>
OncLive TV: Abdulraheem Yacoub, MD
<< Back to Our Featured Experts
Dr. Yacoub on Pegylated Interferon Treatment for PV
Oncology Specialists
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Denise R. Aberle, MD
Amy P. Abernethy, MD, PhD
Wassim Abida, MD, PhD
Ghassan Abou-Alfa, MD
Ghassan K. Abou-Alfa, MD
Jame Abraham, MD
Jeremy S. Abramson, MD
Jeremy Slade Abramson, MD
Sylvia Adams, MD
Julian Adams, PhD
Bonnie Addario
Kerin Adelson, MD,
Alex A. Adjei, MD, PhD
Anjali Advani, MD
Ranjana Advani, MD
Rebecca L. Aft, MD, PhD
Neeraj Agarwal, MD
Sanjiv S. Agarwala, MD
Charu Aggarwal, MD
Rahul Aggarwal, MD
Carol Aghajanian, MD
Giancarlo Agnelli, MD
Demmie Aguilar
Daniel H. Ahn, DO
Daniel H. Ahn, MD
Jing Ai, MD
Wei Z. Ai, MD
Weiyun Z. Ai, MD, PhD
Dara L. Aisner, MD, PhD
Sramila Aithal, MD
Salah-Eddin Al-Batran, MD
Aref Al-Kali, MD
Ahmed N. Al-Niaimi, MD
Kathy S. Albain, MD
David Albala, MD
Steven R. Alberts, MD
Marcus Albertsmeier, MD
Markus Albertsmeier, MD
Laurence Albiges, MD
Haythem Y. Ali, MD
Lani Alison, BCN, MS, HCQ, PCMH, CCE
Andrew R. Allen, BM, BCh, MA, MRCP, PhD
James P. Allison, PhD
Robert S. Alter, MD
Sonja Althammer, PhD
Jessica K. Altman, MD
Ricardo H. Alvarez, MD, MSc
Joseph Alvarnas, MD
Edward P. Ambinder, MD
Jennifer E. Amengual, MD
Asim Amin, MD, PhD
Carey Anders, MD
Jesper Andersen, PhD
Carryn Anderson, MD
Kenneth Anderson, MD
Kenneth C. Anderson, MD
David J. Andorsky, MD
Thierry Andre, MD
Fabrice Andre, MD, PhD
Charalambos (Babis) Andreadis, MD, MSCE
Michael Andreeff, MD, PhD
Dimosthenis Andreou, MD
Robert Andtbacka, MD
Robert H. I. Andtbacka, MD
Christina M. Annunziata, MD, PhD
Stephen Ansell, MD, PhD
Stephen M. Ansell, MD, PhD
Lowell Anthony, MD
Lowell B. Anthony, MD
Emmanuel S. Antonarakis, MBBCh
Scott J. Antonia, MD, PhD
Andrea B. Apolo, MD
John C. Araujo, MD, PhD
Nadir Arber, MD, MHA
David Arenberg, MD
Rebecca Arend, MD
Rebecca C. Arend, MD
Guillem Argiles, MD
Hendrik-Tobias Arkenau, MD, PhD
Josh Armenia, PhD
Joshua Armenia, PhD
Jane M. Armer, RN, PhD
Andrew J. Armstrong, MD
Monica Arnedos, MD
Dirk Arnold, MD
Shagun Arora, MD
Carlos Arteaga, MD
Carlos Arteaga
Banu Arun, MD
Paolo A. Ascierto, MD
Bob Asinof
Michael B. Atkins, MD
Victoria Atkinson, MD
Chloe E. Atreya, MD, PhD
Deanna J. Attai, MD
Igor Aurer, MD
Farrukh Awan, MBBS
FDA Approvals in Myeloma and aTTP, Priority Review Designations in RCC and HNSCC, and More
Trending Now
FDA Approves Adjuvant Pembrolizumab in Stage III Melanoma
Novel Agents Spark New Approaches for Triple-Negative Breast Cancer
CMS Proposes Coverage With Evidence Development for CAR T-Cell Therapy for Cancers
Pembrolizumab Shows Promising Activity in Non-Clear Cell RCC
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
x